HCV core lipid binding domain monoclonal antibodies
US10197573B2 · kind B2 · utility
0Cited by
115References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 2016 |
| Grant date | Feb 5, 2019 |
| Priority date | — |
| Expiry date | Apr 26, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to monoclonal antibodies for the detection of HCV antigen. More specifically, the invention describes antibodies against HCV core antigen lipid binding domain and immunoassay methods, kits and compositions for use in detecting HCV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.